Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2019

01.07.2019 | Health Services Research and Global Oncology

Trends in Volume–Outcome Relationship in Gastrectomies in Texas

verfasst von: Naruhiko Ikoma, MD, MS, Bumyang Kim, PhD, Linda S. Elting, DrPH, Ya-Chen Tina Shih, PhD, Brian D. Badgwell, MD, MS, Paul Mansfield, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

We previously reported a significant volume–outcome relationship in mortality rates after gastrectomies for gastric cancer patients in Texas (1999–2001). We aimed to identify whether changes in the volume distribution of gastrectomies occurred, whether volume–outcome relationships persisted, and potential changes in the factors influencing volume–outcome relationships.

Methods

We performed a population-based study using the Texas Inpatient Public Use Data File between 2010 and 2015. Hospitals were classified as high-volume centers (HVCs, > 15 cases per year), intermediate-volume centers (IVCs, 3–15 cases per year), and low-volume centers (LVCs, < 3 cases per year). We conducted multivariate analyses to evaluate factors associated with inpatient mortality and adverse events.

Results

We identified 2733 gastric cancer patients who underwent gastrectomy at 193 hospitals. Fewer hospitals performed gastrectomy than previously (193 vs. 214). There were more HVCs (5 vs. 2) and LVCs (142 vs. 134), but fewer IVCs (46 vs. 78). The proportion of patients who underwent gastrectomy at HVCs and LVCs increased, while the proportion at IVCs decreased. HVCs maintained lower in-hospital mortality rates than IVCs or LVCs, although mortality rates decreased in both LVCs and IVCs. In adjusted multivariate analyses, treatment at HVCs remained a strong predictor for lower rates of mortality (odds ratio [OR] 0.39, p = 0.019) and adverse events (OR 0.56, p = 0.013).

Conclusion

Despite improvements, patient morbidity and mortality at LVCs and IVCs remain higher than at HVCs, demonstrating that volume–outcome relationships still exist for gastrectomy and that opportunities for improvement remain.
Literatur
1.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.CrossRefPubMed Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–37.CrossRefPubMed
2.
Zurück zum Zitat Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995;221(1):43–9.CrossRefPubMedPubMedCentral Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995;221(1):43–9.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Birkmeyer JD, Dimick JB. Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery. 2004;135(6):569–75.CrossRef Birkmeyer JD, Dimick JB. Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery. 2004;135(6):569–75.CrossRef
4.
Zurück zum Zitat Learn PA, Bach PB. A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care. 2010;48(12):1041–9.CrossRefPubMed Learn PA, Bach PB. A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care. 2010;48(12):1041–9.CrossRefPubMed
5.
Zurück zum Zitat Dikken JL, Dassen AE, Lemmens VE, et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer. 2012;48(7):1004–13.CrossRefPubMed Dikken JL, Dassen AE, Lemmens VE, et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer. 2012;48(7):1004–13.CrossRefPubMed
6.
Zurück zum Zitat Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245(3):426–34.CrossRefPubMedPubMedCentral Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245(3):426–34.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat van der Geest LG, van Rijssen LB, Molenaar IQ, et al. Volume-outcome relationships in pancreatoduodenectomy for cancer. HPB (Oxford). 2016;18(4):317–24.CrossRefPubMedPubMedCentral van der Geest LG, van Rijssen LB, Molenaar IQ, et al. Volume-outcome relationships in pancreatoduodenectomy for cancer. HPB (Oxford). 2016;18(4):317–24.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138(7):721–5 (discussion 726). Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138(7):721–5 (discussion 726).
9.
Zurück zum Zitat Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51.CrossRefPubMed Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280(20):1747–51.CrossRefPubMed
10.
Zurück zum Zitat Hewitt M, Simone JV, editors. Ensuring quality cancer care. Washington, DC: National Academy Press; 1999. Hewitt M, Simone JV, editors. Ensuring quality cancer care. Washington, DC: National Academy Press; 1999.
11.
Zurück zum Zitat Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364(22):2128–2137.CrossRefPubMedPubMedCentral Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011;364(22):2128–2137.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR Jr. Improving the safety of health care: the leapfrog initiative. Eff Clin Pract. 2000;3(6):313–6.PubMed Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR Jr. Improving the safety of health care: the leapfrog initiative. Eff Clin Pract. 2000;3(6):313–6.PubMed
13.
Zurück zum Zitat Smith DL, Elting LS, Learn PA, Raut CP, Mansfield PF. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol. 2007;14(6):1846–52.CrossRefPubMed Smith DL, Elting LS, Learn PA, Raut CP, Mansfield PF. Factors influencing the volume-outcome relationship in gastrectomies: a population-based study. Ann Surg Oncol. 2007;14(6):1846–52.CrossRefPubMed
14.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed
16.
Zurück zum Zitat Iezzoni LI, Daley J, Heeren T, et al. Identifying complications of care using administrative data. Med Care. 1994;32(7):700–15.CrossRefPubMed Iezzoni LI, Daley J, Heeren T, et al. Identifying complications of care using administrative data. Med Care. 1994;32(7):700–15.CrossRefPubMed
17.
Zurück zum Zitat Rosen AK, Geraci JM, Ash AS, McNiff KJ, Moskowitz MA. Postoperative adverse events of common surgical procedures in the Medicare population. Med Care. 1992;30(9):753–65.CrossRefPubMed Rosen AK, Geraci JM, Ash AS, McNiff KJ, Moskowitz MA. Postoperative adverse events of common surgical procedures in the Medicare population. Med Care. 1992;30(9):753–65.CrossRefPubMed
18.
Zurück zum Zitat McCarthy EP, Iezzoni LI, Davis RB, et al. Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care. 2000;38(8):868–76.CrossRefPubMed McCarthy EP, Iezzoni LI, Davis RB, et al. Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care. 2000;38(8):868–76.CrossRefPubMed
19.
Zurück zum Zitat Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data. Is it valid? Med Care. 2000;38(8):785–95. Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data. Is it valid? Med Care. 2000;38(8):785–95.
20.
Zurück zum Zitat Romano PS, Chan BK, Schembri ME, Rainwater JA. Can administrative data be used to compare postoperative complication rates across hospitals? Med Care. 2002;40(10):856–67.CrossRefPubMed Romano PS, Chan BK, Schembri ME, Rainwater JA. Can administrative data be used to compare postoperative complication rates across hospitals? Med Care. 2002;40(10):856–67.CrossRefPubMed
21.
Zurück zum Zitat Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: a follow-up analysis of another decade. Ann Surg. 2009;250(3):472–83.PubMed Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: a follow-up analysis of another decade. Ann Surg. 2009;250(3):472–83.PubMed
22.
Zurück zum Zitat Birkmeyer JD, Lucas FL, Wennberg DE. Potential benefits of regionalizing major surgery in Medicare patients. Eff Clin Pract. 1999;2(6):277–83.PubMed Birkmeyer JD, Lucas FL, Wennberg DE. Potential benefits of regionalizing major surgery in Medicare patients. Eff Clin Pract. 1999;2(6):277–83.PubMed
23.
Zurück zum Zitat Birkmeyer JD. Should we regionalize major surgery? Potential benefits and policy considerations. J Am Coll Surgeons. 2000;190(3):341–9.CrossRefPubMed Birkmeyer JD. Should we regionalize major surgery? Potential benefits and policy considerations. J Am Coll Surgeons. 2000;190(3):341–9.CrossRefPubMed
24.
Zurück zum Zitat Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA. 2000;283(9):1159–66.CrossRefPubMed Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA. 2000;283(9):1159–66.CrossRefPubMed
25.
Zurück zum Zitat Finlayson SR, Birkmeyer JD, Tosteson AN, Nease RF Jr. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37(2):204–9.CrossRefPubMed Finlayson SR, Birkmeyer JD, Tosteson AN, Nease RF Jr. Patient preferences for location of care: implications for regionalization. Med Care. 1999;37(2):204–9.CrossRefPubMed
26.
Zurück zum Zitat Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671–8.CrossRefPubMedPubMedCentral Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671–8.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Modrall JG, Minter RM, Minhajuddin A, et al. The Surgeon Volume-outcome Relationship: Not Yet Ready for Policy. Ann Surg. 2018;267(5):863–7.CrossRefPubMed Modrall JG, Minter RM, Minhajuddin A, et al. The Surgeon Volume-outcome Relationship: Not Yet Ready for Policy. Ann Surg. 2018;267(5):863–7.CrossRefPubMed
28.
Zurück zum Zitat de Wilde RF, Besselink MG, van der Tweel I, et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg. 2012;99(3):404–10.CrossRefPubMed de Wilde RF, Besselink MG, van der Tweel I, et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg. 2012;99(3):404–10.CrossRefPubMed
29.
Zurück zum Zitat Gooiker GA, Lemmens VE, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101(8):1000–05.CrossRefPubMed Gooiker GA, Lemmens VE, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101(8):1000–05.CrossRefPubMed
30.
Zurück zum Zitat Gouma DJ, De Wit LT, Van Berge Henegouwen MI, Van Gulik TH, Obertop H. Hospital experience and hospital mortality following partial pancreaticoduodenectomy in The Netherlands [in Dutch]. Ned Tijdschr Geneeskd. 1997;141(36):1738–41.PubMed Gouma DJ, De Wit LT, Van Berge Henegouwen MI, Van Gulik TH, Obertop H. Hospital experience and hospital mortality following partial pancreaticoduodenectomy in The Netherlands [in Dutch]. Ned Tijdschr Geneeskd. 1997;141(36):1738–41.PubMed
31.
Zurück zum Zitat Busweiler LAD, Dikken JL, Henneman D, et al. The influence of a composite hospital volume on outcomes for gastric cancer surgery: a Dutch population-based study. J Surg Oncol. 2017;115(6):738–45.CrossRefPubMed Busweiler LAD, Dikken JL, Henneman D, et al. The influence of a composite hospital volume on outcomes for gastric cancer surgery: a Dutch population-based study. J Surg Oncol. 2017;115(6):738–45.CrossRefPubMed
32.
Zurück zum Zitat Vicente D, Ikoma N, Chiang YJ, et al. Preoperative therapy for gastric adenocarcinoma is protective for poor oncologic outcomes in patients with complications after gastrectomy. Ann Surg Oncol. 2018;25(9):2720–30.CrossRefPubMed Vicente D, Ikoma N, Chiang YJ, et al. Preoperative therapy for gastric adenocarcinoma is protective for poor oncologic outcomes in patients with complications after gastrectomy. Ann Surg Oncol. 2018;25(9):2720–30.CrossRefPubMed
Metadaten
Titel
Trends in Volume–Outcome Relationship in Gastrectomies in Texas
verfasst von
Naruhiko Ikoma, MD, MS
Bumyang Kim, PhD
Linda S. Elting, DrPH
Ya-Chen Tina Shih, PhD
Brian D. Badgwell, MD, MS
Paul Mansfield, MD
Publikationsdatum
01.07.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07446-0

Weitere Artikel der Ausgabe 9/2019

Annals of Surgical Oncology 9/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.